Bio-Techne (TECH) Non-Current Assets (2009 - 2026)
Bio-Techne (TECH) recorded quarterly Non-Current Assets of $1.9 billion in Q1 2026, down 1.2% quarter-over-quarter from $1.9 billion in Q4 2025, and down 7.66% on a YoY basis from $2.0 billion in Q1 2025.
Bio-Techne (TECH) Non-Current Assets (2009 - 2026) Analysis & Trends
Bio-Techne's Non-Current Assets history runs 18 years deep, the most recent figure standing at $1.9 billion for Q1 2026.
- In Q1 2026, Non-Current Assets fell 7.66% year-over-year to $1.9 billion; the TTM figure through Mar 2026 stood at $7.7 billion (down 6.9% YoY), while the FY2025 annual figure was $245.7 million, down 2.16% from the prior year.
- Non-Current Assets was $1.9 billion for Q1 2026 at Bio-Techne, down from $1.9 billion in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $2.2 billion in Q3 2023 to a low of $223.2 million in Q2 2022.
- Historically, Non-Current Assets has averaged $1.6 billion across 5 years, with a median of $1.9 billion in 2025.
- The sharpest annual moves came in 2023 and 2025: Non-Current Assets climbed 20.3% in 2023, then decreased 8.18% in 2025.
- A 5-year view of Non-Current Assets shows it stood at $1.8 billion in 2022, then rose by 19.01% to $2.1 billion in 2023, then slipped by 4.87% to $2.0 billion in 2024, then dropped by 7.39% to $1.9 billion in 2025, then slipped by 1.2% to $1.9 billion in 2026.
- The last three Non-Current Assets figures came in at $1.9 billion (Q1 2026), $1.9 billion (Q4 2025), and $1.9 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 62,953.78 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 4.56 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 486.60 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 30.30 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 5.18 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.75 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 39.71 Mn |
| 10 | Bio-Techne | 9.04 Bn | 8.83 Bn | 208.29 Mn | 1.86 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.86 Bn |
| Dec 31, 2025 | 1.89 Bn |
| Sep 30, 2025 | 1.92 Bn |
| Jun 30, 2025 | 245.72 Mn |
| Mar 31, 2025 | 2.02 Bn |
| Dec 31, 2024 | 2.04 Bn |
| Sep 30, 2024 | 2.09 Bn |
| Jun 30, 2024 | 251.15 Mn |
| Mar 31, 2024 | 2.11 Bn |
| Dec 31, 2023 | 2.14 Bn |
| Sep 30, 2023 | 2.16 Bn |
| Jun 30, 2023 | 226.20 Mn |
| Mar 31, 2023 | 2.03 Bn |
| Dec 31, 2022 | 1.80 Bn |
| Sep 30, 2022 | 1.80 Bn |
| Jun 30, 2022 | 223.24 Mn |
| Mar 31, 2022 | 1.71 Bn |
| Dec 31, 2021 | 1.71 Bn |
| Sep 30, 2021 | 1.73 Bn |
| Jun 30, 2021 | 207.91 Mn |